March 18 (Reuters) - Madrigal Pharmaceuticals said on Monday it has commenced an underwritten public offering of $500 million in shares of its common stock and pre-funded warrants to purchase common stock. (Reporting by Mariam Sunny in Bengaluru)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
244.7 USD | +3.60% | +7.90% | +4.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.12% | 5.03B | |
+14.67% | 118B | |
+13.64% | 106B | |
-2.56% | 24.28B | |
+1.14% | 21.96B | |
-9.37% | 18.16B | |
-42.28% | 16.37B | |
-16.64% | 15.56B | |
+6.27% | 13.63B | |
+29.63% | 12.27B |
- Stock Market
- Equities
- MDGL Stock
- News Madrigal Pharmaceuticals, Inc.
- Madrigal commences $500 million public offering of common stock